Weiguo Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Weiguo Wang has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Jia Deng
Department of Spine Surgery, Want Want Hospital, Changsha, China
2 shared publicationsShijie Chen
Department of Orthopaedics, The Third Xiangya Hospital of Central South University, Changsha, China
2 shared publications- Shijie Chen
Department of Orthopaedics, Third Xiangya Hospital, Central South University, Changsha 410013, China
2 shared publications - Shijie Chen
Lanzhou University Second Hospital Lanzhou PR China
2 shared publications Xiaofang Zang
Department of Orthopaedics, Third Xiangya Hospital, Central South University, Changsha 410013, China
2 shared publicationsAnjie Min
Department of Oral and Maxillofacial Surgery Center of Stomatology Xiangya Hospital, Central South University Changsha 410078 P. R. China
1 shared publication
Latest Publications
- Open Access
- 3 November 2025
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 41 (1) , 1-18
m6A-mediated silencing of RNF41 by METTL3/YTHDC1 disrupts autophagy to drive intervertebral disc degeneration
Background Intervertebral disc (IVD) degeneration (IDD) represents a predominant origin of low back pain and disability, yet current therapeutic interventions remain suboptimal. Emerging evidence highlights autophagy activation as a therapeutic strategy against IDD. This study investigates the mechanistic interplay between N6-methyladenosine (m6A) modifications and autophagy dysregulation in IDD pathogenesis. Methods Bioinformatics analysis identified ring finger protein 41 (RNF41) as a key autophagy-IDD intersection gene. Functional validation utilized tert-butyl hydroperoxide (TBHP)-treated human nucleus pulposus (NP) cells to assess RNF41’s effects on senescence (CDKN2A), autophagy (LC3-II/p62), apoptosis (TUNEL), inflammation (IL-18/IL-1β), and extracellular matrix (ECM) homeostasis (aggrecan/MMP). Key m6A regulators modulating autophagy were screened via correlation analysis. In vivo validation employed adeno-associated virus (AAV)-mediated methyltransferase-like 3 (METTL3)/RNF41 delivery in puncture-induced IDD rat models. Results RNF41 expression was downregulated in human IVD tissues. Overexpression of RNF41 mitigated TBHP-induced senescence, apoptosis, activated AMPK/mTOR-mediated autophagy, suppressed inflammation, and restored ECM balance. The autophagy inhibitor chloroquine (CQ) abolished the protective effects of RNF41 overexpression on degenerative NP cells. Mechanistically, METTL3/YTHDC1 co-regulation in degenerative NP cells mediated m6A hypermethylation of RNF41 mRNA, shortening its half-life via YTHDC1-dependent decay. Intradiscal METTL3-silencing AAV attenuated puncture-induced disc loss and histopathological degeneration, whereas RNF41-silencing AVV exacerbated ECM disruption and annular disorganization. Conclusion METTL3/YTHDC1-mediated m6A modification drives IDD progression by silencing RNF41, thereby impairing autophagy and ECM integrity. Targeting this axis offers a clinically actionable strategy to delay disc degeneration, particularly in patients with early-stage IDD. This evidence establishes RNF41’s role as a theragnostic biomarker and therapeutic targe, enabling precision-guided interventional approaches.
- 3 November 2025
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 41 (1) , 1-18
Open Accessm6A-mediated silencing of RNF41 by METTL3/YTHDC1 disrupts autophagy to drive intervertebral disc degeneration
Background Intervertebral disc (IVD) degeneration (IDD) represents a predominant origin of low back pain and disability, yet current therapeutic interventions remain suboptimal. Emerging evidence highlights autophagy activation as a therapeutic strategy against IDD. This study investigates the mechanistic interplay between N6-methyladenosine (m6A) modifications and autophagy dysregulation in IDD pathogenesis. Methods Bioinformatics analysis identified ring finger protein 41 (RNF41) as a key autophagy-IDD intersection gene. Functional validation utilized tert-butyl hydroperoxide (TBHP)-treated human nucleus pulposus (NP) cells to assess RNF41’s effects on senescence (CDKN2A), autophagy (LC3-II/p62), apoptosis (TUNEL), inflammation (IL-18/IL-1β), and extracellular matrix (ECM) homeostasis (aggrecan/MMP). Key m6A regulators modulating autophagy were screened via correlation analysis. In vivo validation employed adeno-associated virus (AAV)-mediated methyltransferase-like 3 (METTL3)/RNF41 delivery in puncture-induced IDD rat models. Results RNF41 expression was downregulated in human IVD tissues. Overexpression of RNF41 mitigated TBHP-induced senescence, apoptosis, activated AMPK/mTOR-mediated autophagy, suppressed inflammation, and restored ECM balance. The autophagy inhibitor chloroquine (CQ) abolished the protective effects of RNF41 overexpression on degenerative NP cells. Mechanistically, METTL3/YTHDC1 co-regulation in degenerative NP cells mediated m6A hypermethylation of RNF41 mRNA, shortening its half-life via YTHDC1-dependent decay. Intradiscal METTL3-silencing AAV attenuated puncture-induced disc loss and histopathological degeneration, whereas RNF41-silencing AVV exacerbated ECM disruption and annular disorganization. Conclusion METTL3/YTHDC1-mediated m6A modification drives IDD progression by silencing RNF41, thereby impairing autophagy and ECM integrity. Targeting this axis offers a clinically actionable strategy to delay disc degeneration, particularly in patients with early-stage IDD. This evidence establishes RNF41’s role as a theragnostic biomarker and therapeutic targe, enabling precision-guided interventional approaches.
- 13 April 2023
- Published by Springer Nature in Cell and tissue research
- Vol. 393 (1) , 97-109
The long non-coding RNA KLF3-AS1/miR-10a-3p/ZBTB20 axis improves the degenerative changes in human nucleus pulposus cells
Excessive apoptosis of intervertebral disc cells, namely nucleus pulposus (NP) cells, results in decreased cell density and extracellular matrix (ECM) catabolism, hence leading to intervertebral disc degeneration (IVDD). As a cell model in the present study, a commercially available human NP cell line was utilized. Long noncoding RNAs and microRNAs may regulate the proliferation or apoptosis of human NP cells, hence exerting a significant influence on the occurrence of IVDD. KLF3-AS1 was discovered to be abnormally downregulated in IVDD tissues. Overexpression of KLF3-AS1 enhanced NP cell viability, prevented cell apoptosis, boosted ECM synthesis, and lowered MMP-13 and ADAMTS4 levels. ZBTB20 and KLF3-AS1 were co-expressed in IVDD; ZBTB20 overexpression had similar effects on NP cells, ECM production, and MMP-13 and ADAMTS4 levels as KLF3-AS1 overexpression. miR-10a-3p may target KLF3-AS1 and ZBTB20 and inhibit the expression of ZBTB20. Inhibition of miR-10a-3p enhanced NP cell viability, reduced apoptosis, and enhanced ECM synthesis. KLF3-AS1 overexpression increased ZBTB20 expression, whereas miR-10a-3p overexpression decreased ZBTB20 expression; miR-10a-3p overexpression reduced the effects of KLF3-AS1 on ZBTB20. Overexpression of miR-10a-3p consistently decreased the effects of KLF3-AS1 overexpression on NP cell survival, apoptosis, and ECM synthesis. In conclusion, KLF3-AS1 overexpression may ameliorate degenerative NP cell alterations through the miR-10a-3p/ZBTB20 axis.
- 13 April 2023
- Published by Springer Nature in Cell and tissue research
- Vol. 393 (1) , 97-109
The long non-coding RNA KLF3-AS1/miR-10a-3p/ZBTB20 axis improves the degenerative changes in human nucleus pulposus cells
Excessive apoptosis of intervertebral disc cells, namely nucleus pulposus (NP) cells, results in decreased cell density and extracellular matrix (ECM) catabolism, hence leading to intervertebral disc degeneration (IVDD). As a cell model in the present study, a commercially available human NP cell line was utilized. Long noncoding RNAs and microRNAs may regulate the proliferation or apoptosis of human NP cells, hence exerting a significant influence on the occurrence of IVDD. KLF3-AS1 was discovered to be abnormally downregulated in IVDD tissues. Overexpression of KLF3-AS1 enhanced NP cell viability, prevented cell apoptosis, boosted ECM synthesis, and lowered MMP-13 and ADAMTS4 levels. ZBTB20 and KLF3-AS1 were co-expressed in IVDD; ZBTB20 overexpression had similar effects on NP cells, ECM production, and MMP-13 and ADAMTS4 levels as KLF3-AS1 overexpression. miR-10a-3p may target KLF3-AS1 and ZBTB20 and inhibit the expression of ZBTB20. Inhibition of miR-10a-3p enhanced NP cell viability, reduced apoptosis, and enhanced ECM synthesis. KLF3-AS1 overexpression increased ZBTB20 expression, whereas miR-10a-3p overexpression decreased ZBTB20 expression; miR-10a-3p overexpression reduced the effects of KLF3-AS1 on ZBTB20. Overexpression of miR-10a-3p consistently decreased the effects of KLF3-AS1 overexpression on NP cell survival, apoptosis, and ECM synthesis. In conclusion, KLF3-AS1 overexpression may ameliorate degenerative NP cell alterations through the miR-10a-3p/ZBTB20 axis.
- 14 February 2022
- Published by Springer Nature in Human Cell
- Vol. 35 (3) , 779-791
MiR-1260b protects against LPS-induced degenerative changes in nucleus pulposus cells through targeting TCF7L2
Nucleus pulposus (NP) cells play a critical role in maintaining intervertebral disc integrity through producing the components of extracellular matrix (ECM). NP cell dysfunction, including senescence and hyper-apoptosis, has been regarded as critical events during intervertebral disc degeneration development. In the present study, we found that Transcription Factor 7-Like 2 (TCF7L2) was overexpressed within degenerative intervertebral disc tissue samples, and TCF7L2 silencing improved lipopolysaccharide (LPS)-induced repression on NP cell proliferation, ECM synthesis, and LPS-induced NP cell senescence. miR-1260b directly targeted TCF7L2 and inhibited TCF7L2 expression. miR-1260b overexpression improved LPS-induced degenerative changes in NP cells; more importantly, TCF7L2 overexpression significantly reversed the effects of miR-1260b overexpression on LPS-stimulated degenerative changes within NP cells. For the first time, we demonstrated the function of the miR-1260b/TCF7L2 axis on the phenotypic maintenance of chondrocyte-like NP cells and ECM synthesis by NP cells under LPS stimulation.
- 14 February 2022
- Published by Springer Nature in Human Cell
- Vol. 35 (3) , 779-791
MiR-1260b protects against LPS-induced degenerative changes in nucleus pulposus cells through targeting TCF7L2
Nucleus pulposus (NP) cells play a critical role in maintaining intervertebral disc integrity through producing the components of extracellular matrix (ECM). NP cell dysfunction, including senescence and hyper-apoptosis, has been regarded as critical events during intervertebral disc degeneration development. In the present study, we found that Transcription Factor 7-Like 2 (TCF7L2) was overexpressed within degenerative intervertebral disc tissue samples, and TCF7L2 silencing improved lipopolysaccharide (LPS)-induced repression on NP cell proliferation, ECM synthesis, and LPS-induced NP cell senescence. miR-1260b directly targeted TCF7L2 and inhibited TCF7L2 expression. miR-1260b overexpression improved LPS-induced degenerative changes in NP cells; more importantly, TCF7L2 overexpression significantly reversed the effects of miR-1260b overexpression on LPS-stimulated degenerative changes within NP cells. For the first time, we demonstrated the function of the miR-1260b/TCF7L2 axis on the phenotypic maintenance of chondrocyte-like NP cells and ECM synthesis by NP cells under LPS stimulation.
- 1 February 2021
- Published by Wiley in Advanced Engineering Materials
- Vol. 23 (4) , 2001098
Mechanical Alloying of Immiscible Metallic Systems: Process, Microstructure, and Mechanism
Immiscible metallic systems provide new opportunities for tailoring material properties due to their unique microstructure. However, they are immiscible in the liquid state, or separate into incompatible liquid phase during the cooling process, making it difficult to obtain their alloys or phases. Mechanical alloying is a solid‐state processing route, whose basic principle is to utilize mechanical impact to make materials suffer cyclic deforming, fracturing, and welding. It reduces the energy barrier and provides pathways of atom diffusion, achieving atomic‐level alloying in solid‐state. Notably, mechanical alloying does not undergo the cooling process from liquid to solid phase, which can avoid the solute separation. This article discusses the mechanical alloying process, microstructure, and mechanism of immiscible metallic systems. It focuses on the alloying principles, including solid solutions, intermetallic compounds, nanocrystalline or amorphous alloys. In addition, the effects of process parameters, including rotation speed, milling time, and ball‐to‐powder weight ratio, on microstructure and phase constitution are comprehensively reviewed. Some useful suggestions regarding the preparation of immiscible metallic systems are also put forward for future works.
- 1 February 2021
- Published by Wiley in Advanced Engineering Materials
- Vol. 23 (4) , 2001098
Mechanical Alloying of Immiscible Metallic Systems: Process, Microstructure, and Mechanism
Immiscible metallic systems provide new opportunities for tailoring material properties due to their unique microstructure. However, they are immiscible in the liquid state, or separate into incompatible liquid phase during the cooling process, making it difficult to obtain their alloys or phases. Mechanical alloying is a solid‐state processing route, whose basic principle is to utilize mechanical impact to make materials suffer cyclic deforming, fracturing, and welding. It reduces the energy barrier and provides pathways of atom diffusion, achieving atomic‐level alloying in solid‐state. Notably, mechanical alloying does not undergo the cooling process from liquid to solid phase, which can avoid the solute separation. This article discusses the mechanical alloying process, microstructure, and mechanism of immiscible metallic systems. It focuses on the alloying principles, including solid solutions, intermetallic compounds, nanocrystalline or amorphous alloys. In addition, the effects of process parameters, including rotation speed, milling time, and ball‐to‐powder weight ratio, on microstructure and phase constitution are comprehensively reviewed. Some useful suggestions regarding the preparation of immiscible metallic systems are also put forward for future works.
- 3 November 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 121 (2) , 1664-1674
miR‐181b/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation
The activation of osteoblasts is significantly correlated to prostate tumor bone metastasis and bone loss. Oncostatin M (OSM) could promote breast cancer metastasis to bone. However, its role and mechanism in prostate cancer bone metastasis remain unclear. MicroRNAs (miRNAs) could play important roles in cancers via post‐transcriptionally regulating target genes via binding to specific sequences in the 3′ UTR of downstream target genes. In the present study, we performed microarray profiling analyses to identify differentially‐expressed miRNAs in preosteoclast before and after osteoclast differentiation that could target OSM. miR‐181b‐5p was downregulated during Raw264.7 cells differentiation into osteoclast. By direct targeting OSM 3′ UTR, miR‐181b‐5p inhibited OSM messenger RNA expression and protein levels, subsequently decreasing IL‐6 and AREG and increasing OPG, while OSM overexpression exerted an opposing effect. More importantly, co‐culture with miR‐181b‐5p‐overexpressing differentiated Raw264.7 cells suppressed proliferation, migration, and invasion of mouse prostate cancer RM‐1 cells, while co‐culture with OSM‐overexpressing Raw264.7 cells led to opposing cellular effects. More importantly, the effects of miR‐181b‐5p on osteoclastogenic factors and RM‐1 cells could be significantly reversed by OSM overexpression. In summary, miR‐181b‐5p/OSM axis could be a viable therapeutic target for patients with surgically removed primary tumors to reduce bone metastasis and prevent bone loss.
- 3 November 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 121 (2) , 1664-1674
miR‐181b/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation
The activation of osteoblasts is significantly correlated to prostate tumor bone metastasis and bone loss. Oncostatin M (OSM) could promote breast cancer metastasis to bone. However, its role and mechanism in prostate cancer bone metastasis remain unclear. MicroRNAs (miRNAs) could play important roles in cancers via post‐transcriptionally regulating target genes via binding to specific sequences in the 3′ UTR of downstream target genes. In the present study, we performed microarray profiling analyses to identify differentially‐expressed miRNAs in preosteoclast before and after osteoclast differentiation that could target OSM. miR‐181b‐5p was downregulated during Raw264.7 cells differentiation into osteoclast. By direct targeting OSM 3′ UTR, miR‐181b‐5p inhibited OSM messenger RNA expression and protein levels, subsequently decreasing IL‐6 and AREG and increasing OPG, while OSM overexpression exerted an opposing effect. More importantly, co‐culture with miR‐181b‐5p‐overexpressing differentiated Raw264.7 cells suppressed proliferation, migration, and invasion of mouse prostate cancer RM‐1 cells, while co‐culture with OSM‐overexpressing Raw264.7 cells led to opposing cellular effects. More importantly, the effects of miR‐181b‐5p on osteoclastogenic factors and RM‐1 cells could be significantly reversed by OSM overexpression. In summary, miR‐181b‐5p/OSM axis could be a viable therapeutic target for patients with surgically removed primary tumors to reduce bone metastasis and prevent bone loss.
- 14 September 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (2) , 1763-1772
Interleukin‐1β/nuclear factor‐κB signaling promotes osteosarcoma cell growth through the microRNA‐181b/phosphatase and tensin homolog axis
So far, microRNA has attracted plenty of interest due to its role in tumorigenesis. Reportedly, miR‐181b may be involved in the tumorigenesis of osteosarcoma (OS). In the current study, we attempted to investigate the detailed function and mechanism of miR‐181b in OS carcinogenesis. Herein, miR‐181a, miR‐181b, miR‐181c, and miR‐181d expressions in OS tissues were higher than that in nontumor tissue samples as examined real‐time polymerase chain reaction. Via direct targeting, miR‐181b negatively regulated the expression of phosphatase and tensin homolog (PTEN), a well‐known tumor suppressor. Furthermore, a small interfering RNA strategy was used to find that interleukin (IL)‐1B and nuclear factor‐κB (NF‐κB) regulate miR‐181b and PTEN expression. Consequently, the repression of PTEN by miR‐181b promotes OS cell proliferation. In summary, our data support a critical role for NF‐κB‐dependent upregulation of miR‐181b, which further inhibited PTEN expression and promoted the cell proliferation of OS cell lines. The above findings represent a new pathway for the repression of PTEN and the promotion of cell proliferation upon IL‐1β induction.
- 14 September 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (2) , 1763-1772
Interleukin‐1β/nuclear factor‐κB signaling promotes osteosarcoma cell growth through the microRNA‐181b/phosphatase and tensin homolog axis
So far, microRNA has attracted plenty of interest due to its role in tumorigenesis. Reportedly, miR‐181b may be involved in the tumorigenesis of osteosarcoma (OS). In the current study, we attempted to investigate the detailed function and mechanism of miR‐181b in OS carcinogenesis. Herein, miR‐181a, miR‐181b, miR‐181c, and miR‐181d expressions in OS tissues were higher than that in nontumor tissue samples as examined real‐time polymerase chain reaction. Via direct targeting, miR‐181b negatively regulated the expression of phosphatase and tensin homolog (PTEN), a well‐known tumor suppressor. Furthermore, a small interfering RNA strategy was used to find that interleukin (IL)‐1B and nuclear factor‐κB (NF‐κB) regulate miR‐181b and PTEN expression. Consequently, the repression of PTEN by miR‐181b promotes OS cell proliferation. In summary, our data support a critical role for NF‐κB‐dependent upregulation of miR‐181b, which further inhibited PTEN expression and promoted the cell proliferation of OS cell lines. The above findings represent a new pathway for the repression of PTEN and the promotion of cell proliferation upon IL‐1β induction.
- Open Access
- 1 January 2018
- Published by Termedia Sp. z.o.o. in Journal of Contemporary Brachytherapy
- Vol. 10 (4) , 360-367
Comparison of clinical efficacy and complications of 125I seed brachytherapy and stereotactic body radiation therapy for recurrent pulmonary metastases from colorectal carcinoma
Purpose To evaluate the efficacies of 125I seed implantation and stereotactic body radiation therapy (SBRT) in treatment of recurrent lung metastases from colorectal cancer, to compare the tolerance of lung tissue to both forms of radiotherapy, and to analyze the factors that affect the...
- 1 January 2018
- Published by Termedia Sp. z.o.o. in Journal of Contemporary Brachytherapy
- Vol. 10 (4) , 360-367
Open AccessComparison of clinical efficacy and complications of 125I seed brachytherapy and stereotactic body radiation therapy for recurrent pulmonary metastases from colorectal carcinoma
Purpose To evaluate the efficacies of 125I seed implantation and stereotactic body radiation therapy (SBRT) in treatment of recurrent lung metastases from colorectal cancer, to compare the tolerance of lung tissue to both forms of radiotherapy, and to analyze the factors that affect the...
- 1 August 2016
- Vol. 41 (8)
[miR-181a promotes the proliferation and metastasis of osteosarcoma cells by targeting RASSF1A].
To investigate the role of miR-181a in promoting the proliferation and metastasis of osteosarcoma cells by targeting RASSF1A.
- 1 August 2016
- Vol. 41 (8)
[miR-181a promotes the proliferation and metastasis of osteosarcoma cells by targeting RASSF1A].
To investigate the role of miR-181a in promoting the proliferation and metastasis of osteosarcoma cells by targeting RASSF1A.
- 11 January 2016
- Published by Springer Nature in Tumor Biology
- Vol. 37 (7) , 8869-8877
The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway
Ras-association domain family 1 isoform A (RASSF1A) is a tumor suppressor gene and its expression is lost in numerous types of cancer cells, including primary osteosarcoma cells. However, its functional significance in osteosarcoma has not been well defined. The messenger RNA (mRNA) expression of RASSF1A in osteosarcoma tissues and corresponding non-tumoral tissues was measured by real-time PCR. Overexpression of RASSF1A was established by an adenoviral vector expressing RASSF1A. Cell migration and invasion were analyzed in transwells. Apoptosis and cell cycle were analyzed using flow cytometry. Wnt/β-catenin activity was measured by TCF reporter dual-luciferase assay. Cell viability was measured by MTT assay. Protein expression was detected by Western blot. RASSF1A mRNA expression was significantly lower in osteosarcoma tissues than that in the corresponding non-tumoral tissues. The lowered RASSF1A expression correlated with the clinical severity of osteosarcoma. rAd-RASSF1A injection significantly inhibited the growth of xenograft MNNG/HOS tumors in mice. Overexpression of RASSF1A resulted in significant inhibition of the proliferation, migration, and invasion; induced apoptosis; and arrested cell cycle at G0/G1 phase in both the MNNG/HOS and SaOS2 cells. Overexpression of RASSF1A inhibited the Wnt/β-catenin activity, decreased phosphorylation of Akt/glycogen synthase kinase-3-β (GSK3-β), and increased phosphorylation of mammalian sterile 20-like kinase 1 (MST1). Overexpression of RASSF1A downregulated the cyclin D1, c-Myc, and matrix metalloproteinase-7 (MMP-7) protein levels. RASSF1A functions as a tumor suppressor in osteosarcoma and exerts anti-cancer roles through regulating Akt/GSK-3-Wnt/β-catenin signaling.
- 11 January 2016
- Published by Springer Nature in Tumor Biology
- Vol. 37 (7) , 8869-8877
The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway
Ras-association domain family 1 isoform A (RASSF1A) is a tumor suppressor gene and its expression is lost in numerous types of cancer cells, including primary osteosarcoma cells. However, its functional significance in osteosarcoma has not been well defined. The messenger RNA (mRNA) expression of RASSF1A in osteosarcoma tissues and corresponding non-tumoral tissues was measured by real-time PCR. Overexpression of RASSF1A was established by an adenoviral vector expressing RASSF1A. Cell migration and invasion were analyzed in transwells. Apoptosis and cell cycle were analyzed using flow cytometry. Wnt/β-catenin activity was measured by TCF reporter dual-luciferase assay. Cell viability was measured by MTT assay. Protein expression was detected by Western blot. RASSF1A mRNA expression was significantly lower in osteosarcoma tissues than that in the corresponding non-tumoral tissues. The lowered RASSF1A expression correlated with the clinical severity of osteosarcoma. rAd-RASSF1A injection significantly inhibited the growth of xenograft MNNG/HOS tumors in mice. Overexpression of RASSF1A resulted in significant inhibition of the proliferation, migration, and invasion; induced apoptosis; and arrested cell cycle at G0/G1 phase in both the MNNG/HOS and SaOS2 cells. Overexpression of RASSF1A inhibited the Wnt/β-catenin activity, decreased phosphorylation of Akt/glycogen synthase kinase-3-β (GSK3-β), and increased phosphorylation of mammalian sterile 20-like kinase 1 (MST1). Overexpression of RASSF1A downregulated the cyclin D1, c-Myc, and matrix metalloproteinase-7 (MMP-7) protein levels. RASSF1A functions as a tumor suppressor in osteosarcoma and exerts anti-cancer roles through regulating Akt/GSK-3-Wnt/β-catenin signaling.
- 1 June 2014
- Vol. 39 (6)
[Surgical correction of post-traumatic thoracolumbar kyphotic deformity with posterior transpedicular limited osteotomy technique].
To evaluate the clinical outcome of surgical management for post-traumatic thoracolumbar kyphotic deformity with single-stage posterior transpedicularlimited osteotomies.
- 1 June 2014
- Vol. 39 (6)
[Surgical correction of post-traumatic thoracolumbar kyphotic deformity with posterior transpedicular limited osteotomy technique].
To evaluate the clinical outcome of surgical management for post-traumatic thoracolumbar kyphotic deformity with single-stage posterior transpedicularlimited osteotomies.